COV.AX · CLEO DIAGNOSTICS LTD
Australia · RS rating 41 · As of 2026-10-14
| Price | 0.33 AUD |
|---|---|
| 1-day change | -4.3% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 85 / 41 / 63 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 19 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +61.9% |
| Market cap (USD) | $31.2M |